Journey Medical CorporationDERMNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank20
3Y CAGR-25.5%
5Y CAGR+33.4%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-25.5%/yr
vs -36.2%/yr prior
5Y CAGR
+33.4%/yr
Recent deceleration
Acceleration
+10.7pp
Accelerating
Percentile
P20
Within normal range
vs 5Y Ago
4.2x
Strong expansion
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$20.30M-26.0%
2023$27.44M-14.3%
2022$32.00M-34.8%
2021$49.08M+495.2%
2020$8.25M+71.8%
2019$4.80M-95.4%
2018$104.98M-64.5%
2017$295.92M+608.1%
2016$41.79M-61.0%
2015$107.24M-